Prothena
PRTA
#6872
Rank
โ‚น53.53 B
Marketcap
โ‚น994.49
Share price
-0.81%
Change (1 day)
-15.70%
Change (1 year)

Revenue for Prothena (PRTA)

Revenue in 2025 (TTM): โ‚น1.01 Billion

According to Prothena's latest financial reports the company's current revenue (TTM ) is โ‚น1.05 Billion. In 2024 the company made a revenue of โ‚น11.59 Billion an increase over the revenue in the year 2023 that were of โ‚น7.60 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Prothena from 2012 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น1.01 B-91.23%
2024 โ‚น11.59 B52.43%
2023 โ‚น7.60 B70.52%
2022 โ‚น4.46 B-70.12%
2021 โ‚น14.92 B23831.38%
2020 โ‚น62.38 M7.47%
2019 โ‚น58.04 M-13.07%
2018 โ‚น66.77 M-96.2%
2017 โ‚น1.75 B2350.9%
2016 โ‚น71.69 M-32.87%
2015 โ‚น0.10 B-96.69%
2014 โ‚น3.22 B7617.37%
2013 โ‚น41.76 M-71.3%
2012 โ‚น0.14 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
Alkermes
ALKS
โ‚น136.67 B 12,808.01%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Alnylam Pharmaceuticals
ALNY
โ‚น288.38 B 27,136.30%๐Ÿ‡บ๐Ÿ‡ธ USA
Amarin Corporation
AMRN
โ‚น20.36 B 1,823.76%๐Ÿ‡ฎ๐Ÿ‡ช Ireland